SAT-404-Discordant NS5a but not NS3 RASs profile in liver and plasma compartments of HIV/HCV genotype 1a/4d infected patients

Riccardo Vercesi(IRCCS Ospedale San Raffaele), Sabrina Bagaglio(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Giulia Morsica(Vita-Salute San Raffaele University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Hamid Hasson(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University)
Journal of Hepatology
April 1, 2019
10.1016/s0618-8278(19)31623-8
Cited by 0

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173